Bellevue Group Ag Karuna Therapeutics, Inc. Transaction History

Bellevue Group Ag

  • $6.38 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$161.01 - $317.85 $128,808 - $254,280
-800 Reduced 11.59%
6,100 $1.93 Million
Q3 2023

Nov 14, 2023
SELL
$164.66 - $218.08 $526,912 - $697,856
-3,200 Reduced 31.68%
6,900 $1.17 Million
Q2 2023

Aug 14, 2023
BUY
$176.32 - $240.22 $493,696 - $672,616
2,800 Added 38.36%
10,100 $2.19 Million
Q4 2022

Feb 14, 2023
BUY
$191.53 - $236.82 $1.4 Million - $1.73 Million
7,300 New
7,300 $1.43 Million

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email